D&P Bioinnovations is a pioneering brand dedicated to bioinnovation and regenerative medicine. With a team of experts boasting over 42 years of experience in stem cell tissue engineering and over 30 years in translational/regulatory biomedical business, D&P Bioinnovations is at the forefront of developing therapeutic applications to regenerate damaged organs. Led by Dr.

Derek C. Dashti, a renowned entrepreneur and CEO, the brand prides itself on its cutting-edge research and development. Dr.

Dashti, with his extensive background in bioengineering and regenerative medicine, has successfully translated academic research into practical solutions. He has received recognition as a 2020 Allergan Endowed Business Executive healthcare award fellow. D&P Bioinnovations also benefits from the expertise of a distinguished Board of Advisors, including industry leaders like Dr.

Ruth Waterman, Dr. Gail Naughton, and Dr. Michael Bouvet.

These advisors bring invaluable knowledge and experience in their respective fields to drive innovation forward. To learn more about D&P Bioinnovations and their groundbreaking work, visit their website